(Q37476764)

20 August 2017

1 reference

title

Treating ocular toxoplasmosis: current evidence (English)

1 reference

20 August 2017

0 references

Stanford MR

1

1 reference

20 August 2017

Gilbert RE

series ordinal

2

1 reference

20 August 2017

publication date

1 March 2009

1 reference

Memórias do Instituto Oswaldo Cruz

20 August 2017

published in

1 reference

20 August 2017

volume

104

1 reference

20 August 2017

issue

2

1 reference

20 August 2017

page(s)

312-315

1 reference

Is ocular toxoplasmosis caused by prenatal or postnatal infection?

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000200027

Effect of prenatal treatment on the risk of intracranial and ocular lesions in children with congenital toxoplasmosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000200027

Analysis of recurrence patterns associated with toxoplasmic retinochoroiditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000200027

Toxoplasma gondii in primary rat CNS cells: differential contribution of neurons, astrocytes, and microglial cells for the intracerebral development and stage differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000200027

In vitro susceptibility of various genotypic strains of Toxoplasma gondii to pyrimethamine, sulfadiazine, and atovaquone

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000200027

Trimethoprim-sulfamethoxazole therapy for ocular toxoplasmosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000200027

Atovaquone for the treatment of toxoplasma retinochoroiditis in immunocompetent patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000200027

Treatment of uveitis with pyrimethamine (daraprim)

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000200027

Azithromycin for ocular toxoplasmosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000200027

Visual function in human ocular toxoplasmosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000200027

The effect of long-term intermittent trimethoprim/sulfamethoxazole treatment on recurrences of toxoplasmic retinochoroiditis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000200027

Prophylactic photocoagulation of recurrent toxoplasmic retinochoroiditis. A preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000200027

Antibiotics for toxoplasmic retinochoroiditis: an evidence-based systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000200027

The visual field in toxoplasmic retinochoroiditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000200027

10.1590/S0074-02762009000200027

21 January 2018

Identifiers

DOI

1 reference

20 August 2017

1 reference